Experience
Bausch + Lomb; Mitsubishi Tanabe; Ube; Senju
Sandoz, Inc.
Secured a permanent injunction against generic defendants on behalf of Bausch + Lomb, Mitsubishi Tanabe, Ube, and Senju in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic versions of opthalmic drug Bepreve®.
Bausch + Lomb; Mitsubishi Tanabe; Ube; Senju v. Sandoz, Inc., 1:14-cv-01325, D.N.J., Judges Arpert, Hillman, Schneider, Shipp
Bausch & Lomb Incorporated et al
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co.; Bausch + Lomb v. Lupin Ltd.
Senju Pharmaceutical Co.; Bausch + Lomb
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
Dow Pharmaceutical Sciences, Inc. v. Actavis, Inc.
Dow Pharmaceutical Sciences, Inc.
AbbVie Inc.
Shionogi Pharmaceuticals v. Apotex/Sandoz
Shionogi Pharmaceuticals
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.